Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
147,179,178
-
Total 13F shares
-
85,268,721
-
Share change
-
+665,424
-
Total reported value
-
$3,803,185,901
-
Put/Call ratio
-
359%
-
Price per share
-
$44.60
-
Number of holders
-
204
-
Value change
-
+$18,535,233
-
Number of buys
-
102
-
Number of sells
-
83
Institutional Holders of Denali Therapeutics Inc. - COMMON STOCK (DNLI) as of Q4 2021
As of 31 Dec 2021 Denali Therapeutics Inc. - COMMON STOCK (DNLI) had 204 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 85,268,721 shares of stock of the company.
Largest 10 holders included BAILLIE GIFFORD & CO, VANGUARD GROUP INC, BlackRock Inc., Crestline Management, LP, Temasek Holdings (Private) Ltd, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, FMR LLC, GILDER GAGNON HOWE & CO LLC, and Flagship Pioneering Inc..
This table shows 204 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.